Angiotensin converting enzyme polymorphism and ischemic stroke

References

1. ↵
   1. Global Burden of Disease Study 2013 Collaborators

   (2015) Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease study 2013. Lancet 386, 743–800.
2. ↵
   1. Abd-Allah F,
   2. Moustafa RR

   (2014) Burden of Stroke in Egypt: Current Status and Opportunities. Int J Stroke 9, 1105–1108.
3. ↵
   1. Roger VL,
   2. Go AS,
   3. LloydJones DM,
   4. Benjamin EJ,
   5. Berry JD,
   6. Borden WB,
   7. et al.

   (2012) American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics-update: a report from the American Heart Association. Circulation 125, 188–197.
4. ↵
   1. Cheung RTF

   (2014) A systematic approach to the definition of stroke. Austin J Cerebrovasc Dis Stroke 1, 1024.
5. ↵
   1. Boehme AK,
   2. Esenwa C,
   3. Elkind MSV

   (2017) Stroke Risk Factors, Genetics, and Prevention. Circ Res 120, 472–495.
6. ↵
   1. Hachiya T,
   2. Kamatani Y,
   3. Takahashi A,
   4. Hata J,
   5. Furukawa R,
   6. Shiwa Y,
   7. et al.

   (2017) Genetic predisposition to ischemic stroke, Apolygenic risk score. Stroke 48, 253–258.
7. ↵
   1. Danilczyk U,
   2. Eriksson U,
   3. Crackower MA,
   4. Penninger JM

   (2003) A story of two ACEs. J Mol Med (Berl) 81, 227–234.
8. ↵
   1. Niu T,
   2. Chen X,
   3. Xu X

   (2002) Angiotensin converting enzyme gene insertion/deletion polymorphism and cardiovascular disease: therapeutic implications. Drugs 62, 977–993.
9. ↵
   1. Singhab G,
   2. Bhanwera AJS

   (2019) Distribution of angiotensin converting enzyme gene (insertion/deletion) polymorphism in Indian populations. Gene Reports 14, 110–113.
10. ↵
    1. Kalita J,
    2. Somarajan BI,
    3. Kumar B,
    4. Mittal B,
    5. Misra UK

    (2011) A Study of ACE and ADD1 Polymorphism in Ischemic and Hemorrhagic Stroke. Clin Chim Acta 412, 642–646.
11. ↵
    1. Hage V

    (2011) The NIH stroke scale: a window into neurological status. Nursing Spectrum 24, 44–49.
12. ↵
    1. Harris S,
    2. Kurniawan M,
    3. Rasyid A,
    4. Mesiano T,
    5. Hidayat R

    (2018) Cerebral small vessel disease in Indonesia: Lacunar infarction study from Indonesian Stroke Registry 2012–2014. SAGE Open Med.
13. ↵
    1. Te Riet L,
    2. van Esch JH,
    3. Roks AJ,
    4. van den M,
    5. Danser AH

    (2015) Hypertension: renin-angiotensin-aldosterone system alterations. Circ Res 116, 960–975.
14. ↵
    1. Seckin D,
    2. Ilhan N,
    3. Ilhan N,
    4. Ozbay Y

    (2006) The relationship between ACE insertion/deletion polymorphism and coronary artery disease with or without myocardial infarction. Clin Biochem 39, 50–54.
15. ↵
    1. Pera J,
    2. Slowik A,
    3. Dziedzic T,
    4. Wloch D,
    5. Szczudlik A

    (2006) ACE I/D polymorphism in different etiologies of ischemic stroke. Acta Neurol Scand 114, 320–322.
16. ↵
    1. Indrajaya T

    (2011) The Role of ACE Gene Polymorphism on Pathogenesis of Ischemic Stroke. Acta Med Indones 43, 152–157.
17. ↵
    1. Irma IS,
    2. David SG,
    3. Megan CCM,
    4. Jesús HJ,
    5. Mariela BG,
    6. Alfredo LM,
    7. et al.

    (2019) Gene polymorphisms of angiotensin-converting enzyme and angiotensinogen and risk of idiopathic ischemic stroke. Gene 688, 163–170.
18. ↵
    1. Stankovic S,
    2. Stankovic A,
    3. Milika AR,
    4. Jovanovic-Markovic Z,
    5. Alavantic A,
    6. Majkic-Singh N

    (2011) Angiotensin I - Converting Enzyme Gene Polymorphism and Activity in Patients with Ischemic Stroke. EJIFCC 21, 108–117.
19. ↵
    1. Murali V,
    2. Rathika C,
    3. Padma M,
    4. Arun K,
    5. Mosses J,
    6. Neethi AV,
    7. et al.

    (2014) ACE-II genotype and I allele predicts ischemic stroke among males in south India. Meta Gene 2, 661–669.
20. ↵
    1. Markoula S,
    2. Giannopoulos S,
    3. Kostoulas C,
    4. Tatsioni A,
    5. Bouba I,
    6. Maranis S,
    7. et al.

    (2011) Gender association of the angiotensin-converting enzyme gene with ischaemic stroke. J Renin Angiotensin Aldosterone Syst 12, 510–515.
21. ↵
    1. Das S,
    2. Roy S,
    3. Sharma V,
    4. Kaul S,
    5. Jyothy A,
    6. Munsh A,
    7. et al.

    (2015) Association of ACE gene I/D polymorphism and ACE levels with hemorrhagic stroke: comparisonwith ischemic stroke. Neurol Sci 36, 137–142.
22. ↵
    1. Tuncer N,
    2. Tuglular S,
    3. Kiliç G,
    4. Sazci A,
    5. Us O,
    6. Kara I,
    7. et al.

    (2006) Evaluation of the angiotensin-converting enzyme insertion/deletion polymorphism and the risk of ischaemic stroke. J Clin Neurosci 13, 224–227.
23. ↵
    1. Karagiannis A,
    2. Balaska K,
    3. Tziomalos K,
    4. Tokalaki-Nikolaidou L,
    5. Papayeoryiou A,
    6. Zamboulis C,
    7. et al.

    (2004) Lack of an association between angiotensin-converting enzyme gene insertion/deletion polymorphism and ischaemic stroke. Eur Neurol 51, 148–152.
24. ↵
    1. Mostafa MA,
    2. El-Nabiel LM,
    3. Fahmy NA,
    4. Aref H,
    5. Edrees Shreef E,
    6. Abd El-Tawab F,
    7. et al.

    (2016) ACE Gene in Egyptian Ischemic Stroke Patients. J Stroke Cerebrovasc Dis 25, 2167–2171.
25. ↵
    1. Razek M

    (2003) Genetic polymorphism of the angiotensin converting enzyme and beta-fibrinogen genes as risk factors for ischemic stroke (Faculty of Medicine, Cairo University, Cairo).
26. ↵
    1. Han C,
    2. Han XK,
    3. Liu FC,
    4. Huang JF

    (2017) Association between angiotensin-converting enzyme gene insertaion/deletion polymorphism and peripheral vascular disease:Ameta analysis. Chronic Dis Transl Med 3, 230–241.
27. ↵
    1. Hamdy S,
    2. Hiratsuka M,
    3. Narahara K,
    4. El-Enany M,
    5. Moursi N,
    6. Ahmed M,
    7. et al.

    (2002) Allele and genotype frequencies of polymorphic DCP1, CEIP, ADRB2, and HTR2A in the Egyptian population. Eur J Clin Pharmacol 58, 29–36.
28. ↵
    1. Dichgans M,
    2. Pulit SL,
    3. Rosand J

    (2019) Stroke Genetics: Discovery, Biology, and Clinical Applications. Lancet Neurol 18, 587–599.